AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc. (Nasdaq:MIRN), a clinical-stage biopharmaceutical company developing a broad pipeline of microRNA-based oncology therapeutics, today announced that President and Chief Executive Officer Paul Lammers, M.D., M.Sc., will present a corporate overview at the Oppenheimer 26th Annual Healthcare Conference. The presentation will take place at 2:10 p.m. EST on Tuesday, December 8, 2015 at The Westin New York Grand Central in New York City.
